BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Mar 27, 2026; 18(3): 115972
Published online Mar 27, 2026. doi: 10.4240/wjgs.v18.i3.115972
Table 3 Secondary outcomes and nutritional parameters, n (%) or mean ± SD
Outcome
EEN group (n = 52)
DEN group (n = 48)
P value
Feeding intolerance7 (13.5)8 (16.7)0.645
Time to full nutrition (days)4.2 ± 1.6a8.5 ± 2.8b< 0.001
Local complications
    Pancreatic necrosis16 (30.8)18 (37.5)0.473
    Peripancreatic fluid collections22 (42.3)24 (50.0)0.435
    Pancreatic pseudocyst5 (9.6)7 (14.6)0.434
Interventional procedures8 (15.4)a16 (33.3)b0.031
Albumin (g/L)
    Baseline36.4 ± 5.235.8 ± 5.60.579
    Day 734.8 ± 4.6a31.2 ± 5.8b0.001
    Day 1433.2 ± 4.8a28.6 ± 5.4b< 0.001
Prealbumin (mg/L)
    Baseline186 ± 42182 ± 460.646
    Day 7168 ± 38a142 ± 44b0.002
    Day 14172 ± 36a136 ± 48b< 0.001
C-reactive protein day 7 (mg/L)82 ± 34a126 ± 52b< 0.001
Procalcitonin day 7 (ng/mL)1.8 ± 0.9a3.6 ± 1.8b< 0.001


Write to the Help Desk